Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/31/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Kevin P. Starr

Wrong Kevin P. Starr?

Partner

Phone: (617) ***-****  
Email: k***@***.com
Third Rock Ventures LLC
29 Newbury Street
Boston , Massachusetts 02116
United States

Company Description: At Third Rock we seek bold ideas and new frontiers that will pave the way for disruptive technologies and science which promise to dramatically improve the lives of...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Master of Science degree , Corporate Finance
    Boston College
  • Bachelor of Arts degree , Mathematics and Business
    Colby College
  • M.S. , Corporate Finance
    Boston College
  • B.A. , Mathematics and Business
    Colby College
  • MBA training
    Boston College
51 Total References
Web References
Our Team - SAGE Therapeutics
www.sagerx.com, 31 Dec 2015 [cached]
Kevin Starr
Kevin is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Kevin co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. Prior to Third Rock Ventures, Kevin was Chief Operating Officer and Chief Financial Officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. He is currently a Board Member of Alnylam Pharmaceuticals.
Kevin holds a M.S. in Corporate Finance from Boston College and a B.A. in Mathematics and Business from Colby College.
Kevin ...
decibeltx.com, 26 Dec 2015 [cached]
Kevin Starr
Chairman and Interim CEO of Decibel Therapeutics and Partner, Third Rock Ventures
Kevin Starr is chairman and interim CEO of Decibel Therapeutics, a co-founder and partner of Third Rock Ventures, and a proven leader with more than 25 years of experience building and operating leading biotechnology companies.
In his role at Third Rock, Kevin focuses on the formation, development and business strategy of the firm's portfolio companies, actively identifying and evaluating new investments. He has helped successfully raise $1.3 billion through the firm's three funds. Kevin assumes active leadership roles in Third Rock portfolio companies, functioning as chief executive officer through the first 12-18 months after launch. In addition to Decibel, Kevin has been instrumental in launching and building a number of portfolio companies, including Afferent Pharmaceuticals, Agios Pharmaceuticals, Global Blood Therapeutics, MyoKardia, PanOptica, SAGE Therapeutics and Zafgen Pharmaceuticals.
Prior to Third Rock, Kevin served as chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he helped raise billions of dollars in capital through strategic alliances and public financing and drove the company's growth through organic expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Biogen and Digital Equipment Corporation. Kevin holds an M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College. He is currently a board member of Alnylam Pharmaceuticals.
Boston PE.VC Board - Financial Executives Alliance
www.feanetwork.com, 22 Nov 2015 [cached]
Kevin Gillis Partner & CFO Third Rock Ventures
Kevin has approximately 20 years of financial experience, successfully designing, overseeing and managing the financial operations for both newly emerging and established biotech companies. Hejoined Third Rock Ventures in 2008 and oversees the operational, financial and administrative aspects of the firm. He also directs and oversees the initial operational activities for Third Rock portfolio companies.Prior to joining Third Rock Ventures, Kevin was Vice President of Finance at Coley Pharmaceutical Group, supporting the company's successful initial public offering in 2005 and overseeing the finances related to the company's acquisition by Pfizer in 2008. Prior to Coley, Kevin served in a number of senior finance roles at Millennium Pharmaceuticals and The Coca-Cola Company.
Kevin P. ...
investor.sagerx.com, 30 April 2015 [cached]
Kevin P. Starr
Chairman of the Board of Directors
...
Kevin P. Starr . Mr. Starr has served as a member of our Board of Directors since September 2011. In 2007, Mr. Starr co-founded Third Rock Ventures, a venture capital firm where he remains a partner. From 2003 to 2007, Mr. Starr undertook a number of entrepreneurial endeavors in the life science and entertainment industries. From 2001 to 2002, Mr. Starr served as chief operating officer of Millennium Pharmaceuticals, Inc. He also served as Millennium’s chief financial officer from 1998 to 2002. Mr. Starr currently serves on the board of directors of Agios Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., PanOptica, Inc., MyoKardia, Inc., Global Blood Therapeutics, Inc., Afferent Pharmaceuticals, Inc., and Zafgen, Inc. Mr. Starr received an M.S. in corporate finance from Boston College and a B.S./B.A. in mathematics and business from Colby College. Mr. Starr’s qualifications to serve on our Board of Directors include his executive management roles with responsibility over key financial and business planning functions and experience in the formation, development and business strategy of multiple start-up companies in the life sciences sector.
...
Kevin P. Starr (11)
...
Each of Third Rock Ventures II GP, L.P. (“TRV GP”), the general partner of TRV LP, Third Rock Ventures II GP, LLC (“TRV LLC”), the general partner of TRV GP, and Mark Levin, Kevin Starr and Robert Tepper, the managers of TRV LLC, may be deemed to have voting and investment power over the shares held of record by TRV LP.
...
Investment decisions with respect to the shares held by TRV LP are made by an investment committee at TRV GP comprised of Mark Levin, Kevin Starr, and Bob Tepper.
...
Mr. Starr and Dr. Paul are members of our Board of Directors, and Mr. Starr is a managing member of TRV GP, LLC, which is the general partner of Third Rock Ventures GP, L.P., the general partner of Third Rock Ventures, L.P. and a managing member of TRV.
...
Mr. Starr and Dr. Paul are members of our Board of Directors, and Mr. Starr is a managing member of TRV GP, LLC, which is the general partner of Third Rock Ventures GP, L.P., the general partner of Third Rock Ventures, L.P. and a managing member of TRV.
...
These consulting fees were paid to TRV in amounts mutually agreed upon in advance by us and TRV in consideration of certain strategic and ordinary course business operations consulting services provided to us on an as-needed basis, from time to time and at our request, by individuals related to TRV, including Dr. Paul but not including Mr. Starr.
...
None of these consulting fees were paid directly or indirectly to Mr. Starr and Dr. Paul.
...
Our Board of Directors has determined that all members of the Board of Directors, except Dr. Jonas and Mr. Starr, are independent, as determined in accordance with the rules of the NASDAQ Stock Market.
...
Kevin P. Starr
Kevin ...
www.myokardia.com, 7 May 2015 [cached]
Kevin Starr Co-Founder and Partner, Third Rock Ventures
Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. In addition to his role at Third Rock, he also serves as the interim chief executive officer of SAGE Therapeutics. Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. He is currently a board member of Alnylam Pharmaceuticals and SAGE Therapeutics.
Mr. Starr holds a M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.
Other People with the name "Starr":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304